ARCT · Arcturus Therapeutics Holdings Inc.
Market Cap
$449.65M
Shares
28.42M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Joseph E. Payne | President and Chief Executive Officer, Director | $1,691,000 |
| Joseph Payne | CEO | $1,691,000 |
| Andy Sassine | Former Chief Financial Officer | $1,181,500 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $862,000 |
| Lance Kurata | Chief Legal Officer | $830,000 |
| Joe Roberts | Interim Principal Financial Officer and Accounting Officer; Controller | $273,580 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Joseph E. Payne | President and Chief Executive Officer, Director | $3,697,000 |
| Joseph Payne | CEO | $3,697,000 |
| Andy Sassine | Chief Financial Officer, Director | $1,618,000 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $1,585,000 |
| Lance Kurata | Chief Legal Officer | $1,487,000 |
| Joe Roberts | Interim Principal Financial Officer and Accounting Officer; Controller | $405,729 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joseph E. Payne | President and Chief Executive Officer, Director | $4,892,500 |
| Joseph Payne | CEO | $4,892,500 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $3,178,500 |
| Andy Sassine | Chief Financial Officer, Director | $2,182,500 |
| Lance Kurata | Chief Legal Officer | $2,095,000 |
| Joe Roberts | Interim Principal Financial Officer and Accounting Officer; Controller | $347,874 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joseph Payne | CEO | $5,594,000 |
| Joseph E. Payne | President and Chief Executive Officer, Director | $5,594,000 |
| Andy Sassine | Chief Financial Officer, Director | $3,145,375 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $3,106,000 |
| Lance Kurata | Chief Legal Officer | $1,182,000 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joseph Payne | CEO | $960,000 |
| Joseph E. Payne | President and Chief Executive Officer, Director | $960,000 |
| Andy Sassine | Chief Financial Officer, Director | $750,000 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $750,000 |
| Dr. Steven Hughes | Former Chief Medical Officer | $644,000 |
| Lance Kurata | Chief Legal Officer | $560,000 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joseph E. Payne | President and Chief Executive Officer, Director | $12,861,500 |
| Joseph Payne | CEO | $12,861,500 |
| Andy Sassine | Chief Financial Officer | $7,654,800 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $7,472,600 |
| Lance Kurata | Chief Legal Officer | $5,140,550 |
| Dr. Steven Hughes | Former Chief Medical Officer | $4,876,625 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Andy Sassine | Chief Financial Officer | $1,326,880 |
| Joseph Payne | CEO | $1,165,818 |
| Joseph E. Payne | President and Chief Executive Officer, Director | $1,165,818 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $636,156 |
| Dr. Steven Hughes | Former Chief Medical Officer | $299,873 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Joseph E. Payne | President and Chief Executive Officer, Director | $2,687,044 |
| Joseph Payne | CEO | $2,687,044 |
| Padmanabh Chivukula | Chief Scientific Officer, Chief Operating Officer | $1,372,905 |
| Andy Sassine | Chief Financial Officer | $246,340 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dennis Mulroy | Chief Financial Officer | Appointed | 2026-05-07 |
| Joe Roberts | interim principal accounting officer | Appointed | 2025-12-15 |
| Andy Sassine | member of the Company's Board of Directors | Resigned | 2025-12-15 |
| Joe Roberts | interim principal financial officer | Appointed | 2025-12-15 |
| Andy Sassine | Chief Financial Officer | Resigned | 2025-12-15 |
Key facts
CIK
1768224
CUSIP
03969T109
13F (30d)
89 filings
89 filers
Visit website
Investor relations